Monthly Archives: September 2014
New FDA draft guidance risks ‘Confused Consent’
Clinical trials require researchers to ensure that each participant is fully aware of the details of the trial before they take part. The FDA’s recently released draft guidance for Institutional Review Boards (IRBs), clinical investigators and sponsors on Informed Consent … Continue reading
2014 ARCS scientific congress: Naming biosimilar medicines – are we any closer?
2014 ARCS scientific congress: ethics in HTA and decision-making
2014 ARCS Scientific Congress: Plenary Session Day One
commercial eyes recruiting: medical information consultant
Due to ongoing demands in our Medical Services department, we are looking for a Medical Information Consultant who has a Bachelor of Pharmacy or a related discipline, and at least 3 years experience providing drug information to Healthcare professionals and … Continue reading
7 ways to give your Prescription Medicine Registration submission the best chance of success
top 5 essentials to a seamless medical information transition
Partnering with a Medical Information services provider is a great way for you to focus your limited resources on key areas of your business. However, it’s important to give due consideration – as early as possible – to how the … Continue reading
